HRPC(SH:600829) Zheng Quan Zhi Xing·2025-06-26 16:42Meeting Overview - The first meeting of the 11th Board of Directors of Harbin Pharmaceutical Group Renmin Tongtai Pharmaceutical Co., Ltd. was held on June 26, 2025, with all 7 directors present and no dissenting votes [1][2] - The meeting was convened in accordance with the Company Law, Articles of Association, and Board Meeting Rules [1] Resolutions Passed - The election of Zhu Weidong as the Chairman of the 11th Board of Directors was unanimously approved, with a vote of 7 in favor, 0 against, and 0 abstentions [2] - The members of the specialized committees of the 11th Board of Directors were elected as follows: - Strategic Decision Committee: Chairman: Zhu Weidong, Members: Gu Congfeng, Li Wenming - Nomination Committee: Chairman: Li Wenming, Members: Zhu Weidong, Gu Dan - Audit Committee: Chairman: Li Wen, Members: Yin Shiwei, Gu Dan - Compensation and Assessment Committee: Chairman: Gu Dan, Members: Zhu Weidong, Li Wen [2][3] - The appointment of Gu Congfeng as the General Manager was approved, with the same voting results [2] - The appointment of Guan Ping as the Deputy General Manager and Chief Financial Officer was approved, with the same voting results [3] - The appointment of Wang Lei as the Secretary of the Board was approved, with the same voting results [4] Contact Information - The contact details for the Secretary of the Board, Wang Lei, were provided, including phone, fax, email, and office address [4]